期刊文献+

以Insig-2基因启动子为靶点的药物筛选模型的建立 被引量:1

Establishment of drug screening model targeting Insig-2 promoter
下载PDF
导出
摘要 目的通过双荧光素酶报告基因检测系统建立以胰岛素诱导基因2(insulin-induced gene 2,Insig-2)启动子为靶点的药物筛选模型。方法将人Insig-2基因启动子序列克隆入荧光素酶报告基因载体pGL3-basic中,构建重组质粒pGL3-Insig-2并与内参质粒pRL-TK瞬时共转染工具细胞,通过检测荧光素酶报告基因表达水平的变化反映Insig-2基因启动子启动转录的活性,并对共转染质粒比例、工具细胞选择等条件进行探索和优化,相关药物处理进行验证。结果成功构建了重组质粒pGL3-Insig-2;确认pGL3-Insig-2:pRL-TK共转染比例为4∶1,确定3T3-L1细胞为工具细胞;1,25-(OH)2D3、小檗碱和姜黄素均能明显增强Insig-2基因启动子活性。结论成功建立了以Insig-2基因启动子为靶点的药物筛选模型,为筛选新型调脂药奠定基础。 Aim To establish a drug screening model targeting Insig-2 prompter by the dual- luciferase reporter assay system. Methods The Insig-2 promoter fragment was inserted into the vector pGL3-basic. The constructed recombinant plasmid pGL3- Insig-2 and internal reference plasmid pRL-TK were transiently co-transfected to appropriate cells, then the Insig-2 promoter ac- tivity was measured by dual-luciferase reporter assay, and the assay conditions were studied and optimized, such as the ratio of plasmids, the choice of cell lines, and related drug treatment. Results The recombinant plasmid pGL3-Insig-2 was successfully constructed; the ratio between plasmid pGI3-Insig-2 and pRL- TK was 4:1; 333-L1 cell line was chosen as target cell; 1,25- (OH) 2D3, Berberine and Curcumin could significantly enhance the Insig-2 gene promoter activity. Conclusion The drug screening model targeting Insig-2 promoter was successfully es- tablished, which lays an experimental foundation for discovering new lipid-regulators.
出处 《中国药理学通报》 CAS CSCD 北大核心 2014年第1期140-143,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 30600812)
关键词 Insig-2 启动子 药物筛选 报告基因载体 调脂药 荧光素酶法 Insig-2 promoter drug screening reporter genevector lipid-regulators dual- luciferase reporter assay
  • 相关文献

参考文献2

二级参考文献25

  • 1Iizuka N, Hazama S, Yoshimura K, et al. Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma [ J ]. Int J Cancer, 2002,99 (2) :286 -91.
  • 2Kuo C L, Chi C W, Liu T Y. The anti-inflammatory potential of berberine in vitro and in vivo [ J ] . Cancer Lett ,2004 ,203 (2) :127 -37.
  • 3Yabe D, Brown M S, Goldstein J L. Insig-2, a second endoplasmlc rcticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins [ J ]. Proc Natl Acad Sci USA, 2002,99 (20) : 12753 - 8.
  • 4Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins [ J ]. Nat Med,2004,10 ( 12 ) : 1344 - 51.
  • 5Abidi P, Zhou Y, Jiang J D, et al. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine [ J ]. Arterioscler Thromb Vasc Biol,2005 ,25(10 ) :2170 -6.
  • 6Habbert M L, Zhang Y, Lee F Y, et al. Regulation of hepatic Insig- 2 by the farnesoid X receptor[ J]. Mol Endocrinol,2007,21 (6) : 1359 -69.
  • 7Krapivner S, Popov S, Chernogubova E, et al. Insulin-induced gene 2 ( INSIG2 ) involvement in human adipocyte metabolism and body weight regulation [ J ]. J Clin Endocrinol Metab ,2008,93 ( 5 ) : 1995 - 2001.
  • 8Sever N, Song B L, Yabe D, et al. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol [ J ]. J Biol Chem ,2003,278 (52) :52479 - 90.
  • 9Abidi P, Zhou Y, Jiang J D, et al. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medi- cine berberine [J]. Arterioscler Thromb Vasc Biol, 2005, 25(10): 2170-2176.
  • 10Walldius G, Jungner I. Apolipoprotein B and apolipo- proteinA-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy [J]. J lntern Med, 2004, 255(2): 188-205.

共引文献27

同被引文献5

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部